Results 51 to 60 of about 8,334 (133)

Can ammonia scavenging treat MASLD? Evaluating the evidence for L-ornithine L-aspartate-A systematic review. [PDF]

Eur J Clin Invest
Ismaiel A, Ciornolutchii V, Popa SL, Dumitrascu DL.   +3 more
europepmc   +1 more source

MASLD-Induced Hyperammonemia With Atypical, Restricted Diffusion Pattern Suggesting Mixed Metabolic and Hypoxic-Anoxic Injury. [PDF]

HCA Healthc J Med
Thomas R, Nguyen NT, Bao D, Tang J, Ali U, Cao D.   +5 more
europepmc   +1 more source

Sarcopenia modelling by portal vein ligation inducing hyperammonemia in rats. [PDF]

PLoS One
Nadinskaia M, Gulyaeva K, Sukhinin A, Sedova A, Boykova P, Izmailov I, Pokidova K, Kuzmin E, Venediktov A, Meglinski I, Piavchenko G.   +10 more
europepmc   +1 more source

Case Report: Carglumic acid accelerates ammonia clearance in a neonate with methylmalonic acidemia. [PDF]

Front Pediatr
Ma Q, Luo Y, Zhang X, Xu L, Shi D, Shi M, Yu D.   +6 more
europepmc   +1 more source

Valproate-induced hyperammonemic delirium in a patient with bipolar affective disorder: A clinical caution.

Indian J Pharmacol
Gupta S, Tyagi S, Rana S, Prasad S.
europepmc   +1 more source

Hyperammonemic Encephalopathy Caused by Obstructive Urinary Tract Infection Due to Urease-Positive Corynebacterium riegelii in an Elderly Woman: A Case Report. [PDF]

Cureus
Araya T, Kita T, Higashi T, Hara R, Takato H.   +4 more
europepmc   +1 more source

Hyperammonemia increases the release of pathological extracellular vesicles from monocytes by impairing lysosomal function and autophagy through the TNFα-cAMP-PKA-LC3 pathway. [PDF]

Front Immunol
Pedrosa MA, Izquierdo-Altarejos P, Llansola M, Felipo V.   +3 more
europepmc   +1 more source

Clinical and biochemical factors associated with hyperammonemia in inpatients with mental disorders treated with valproic acid: a cross-sectional analysis. [PDF]

Ther Adv Psychopharmacol
Riboldi I, Cavaleri D, Morreale M, Crocamo C, Bartoli F, Carrà G.   +5 more
europepmc   +1 more source

Biochemical, Clinical, and Functional Characterization of a Rare c.-106C>A Promoter Region Variant in Late-Onset Ornithine Transcarbamylase Deficiency: A Multifamily Case Series. [PDF]

JIMD Rep
Tholl SQ, McCaul W, Rupar A, Napier MP, Karp N, Yu AC, Ratko S, Khan A, Geraghty M, Prasad C.   +9 more
europepmc   +1 more source

Perioperative management of pediatric patients with inborn errors of metabolism during liver transplantation. [PDF]

World J Transplant
Paulin S, Rajakumar A, Menon J, Shanmugam N, Rela M.   +4 more
europepmc   +1 more source